BioDot, Inc is a leading company that offers low volume liquid handling solutions for diagnostics and life sciences. Founded in
1994, BioDot has been at the forefront of developing proprietary, quantitative technologies for the dispensing of low volumes of fluids catering to industrial, life science, diagnostic, and medical products. It specializes in the patented BioJet™, "Drop on Demand" non-contact, dispensing technology, initially focusing on applications in the diagnostic marketplace such as Lateral Flow Test or Flow Through Test. Over the years, the company expanded its expertise to include lamination and cutting technologies, offering modular workstations that enable customers to work in a "Batch" or "In-Line" Approach. With a commitment to understanding its customer's requirements globally, BioDot has expanded its global presence to China and the UK/Europe. In
2020, the company secured a private equity round investment from
Artemis Capital Partners, further strengthening its position in the market. With a continuously expanding product portfolio, BioDot remains a leading supplier of system tools for the research, development, and commercialization of diagnostic tests.
#lateralflow, #biosensor, #labonachip, #biochip, #dispensing
